Effectiveness of Empiric Antiviral Treatment for Hospitalized Community Acquired Pneumonia during the Influenza Season
The purpose of this FOA is to provide support for research to determine the effectiveness of empiric influenza antiviral therapy, in addition to standard care, for hospitalized patients with lower respiratory tract illness (LRTI) during the periods when influenza viruses are circulating in the community.
General information about this opportunity
Last Known Status
Deleted 01/08/2014 (Archived.)
Program Number
RFA-IP-14-001 Federal Agency/Office
Agency: Department of Health and Human ServicesOffice: CENTERS FOR DISEASE CONTROL
Type(s) of Assistance Offered
Cooperative Agreement Number of Awards Available
1 Who is eligible to apply/benefit from this assistance?
Applicant Eligibility
Eligible Applicants/Organizations: Dr. Julio Ramirez, University of Louisville, Division of Infectious Diseases, 501 E Broadway, Suite 380, Louisville, KY 40202 What is the process for applying and being award this assistance?
Application Procedure
Application Due Date: December 9, 2013, by 5:00 PM U.S. Eastern Time. Deadlines
12/09/2013 Other Assistance Considerations
Formula and Matching Requirements
This program does not have cost sharing or matching requirements. Who do I contact about this opportunity?
Headquarters Office
CDC Procurement and Grants Office (PGO)
Technical Information Management Section (TIMS)
Phone: 770-488-2700
Website Address
THIS IS NOT AN ACTIVE LINK. PLEASE CLICK ON THE WORDS "FULL ANNOUNCEMENT" AT THE TOP OF THIS PAGE.
E-mail Address
pgotim@cdc.gov
Financial Information
Obligations
$200,000.00 Range and Average of Financial Assistance
Awards range from $150,000.00 to $200,000.00
